| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.008 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |